跳至主要内容
临床试验/IRCT20200328046886N6
IRCT20200328046886N6招募中2 期

Evaluation of the efficacy and safety of colchicine in the prevention for post-CABG atrial fibrillation: a randomized double-blind placebo- controlled trial

Mazandaran University of Medical Sciences0 个研究点目标入组 172 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
172

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patient between 18_80 years old
  • Patient with CAD and candidate for CABG

排除标准

  • Preoperative AF
  • Patients with pacemakers
  • Patient with Clcr<30ml/min
  • Severe hepatic insufficiency or transaminase level more than 3 times higher than normal
  • Breastfeeding or pregnancy
  • Colchicine intolerance or allergy
  • Lack of patients consent to participate in study
  • Presences of sick Sinus syndrom
  • Previous cardiac rhythm disorder,conduction blocks of any degree
  • Co administration with strong pgp and 3A4 inhibitors (voiconazol,ketoconazole,fluconazole,itraconazole,clarithromycin,etc.)
  • Taking anti arrhythmic medicines except beta blockers during past months of surgery

研究者

相似试验